Skip to content

Insmed INSM PARI milestones — Intangibles, net

Similar metrics at other companies

Eastern Company logo
EMLPatents Technology And Other Intangibles Net Of Accumulated Amortization
$5.27M-39.9%
ACV Auctions Inc. logo
ACVAAcquired intangible assets (net of amortization of $42,642 and $40,202)
$78.29M-11.3%
Bentley Systems, Incorporated logo
BSYIntangibles (Net)
$180.72M-10.9%
HubSpot logo
HUBSIntangibles (Net)
$32.51M-20.8%
JFrog Ltd. logo
FROGIntangibles (Net)
$35.24M-35.9%
Tyler Technologies logo
TYLIntangibles (Net)
$755.74M-7.5%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.18B+19.9%
Enterprise value$23.17B+24.5%
P/S28.3×-20.3×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's pari milestones — intangibles, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's PARI milestones — intangibles, net?
Insmed (INSM) reported PARI milestones — intangibles, net of $911K in Q1 2026.
What does PARI milestones — intangibles, net mean?
This represents the net book value of intangible assets acquired through milestone-based agreements related to the PARI product line. It reflects the capitalized cost of intellectual property or licensing rights after accounting for accumulated amortization and impairment. This metric is critical for assessing the long-term value of the company's acquired technology portfolio.